These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 26769750

  • 1. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
    Hayashi T, Gust KM, Wyatt AW, Goriki A, Jäger W, Awrey S, Li N, Oo HZ, Altamirano-Dimas M, Buttyan R, Fazli L, Matsubara A, Black PC.
    Clin Cancer Res; 2016 Jun 15; 22(12):2981-92. PubMed ID: 26769750
    [Abstract] [Full Text] [Related]

  • 2. Unravelling disparate roles of NOTCH in bladder cancer.
    Goriki A, Seiler R, Wyatt AW, Contreras-Sanz A, Bhat A, Matsubara A, Hayashi T, Black PC.
    Nat Rev Urol; 2018 Jun 15; 15(6):345-357. PubMed ID: 29643502
    [Abstract] [Full Text] [Related]

  • 3. NOTCH pathway inactivation promotes bladder cancer progression.
    Maraver A, Fernandez-Marcos PJ, Cash TP, Mendez-Pertuz M, Dueñas M, Maietta P, Martinelli P, Muñoz-Martin M, Martínez-Fernández M, Cañamero M, Roncador G, Martinez-Torrecuadrada JL, Grivas D, de la Pompa JL, Valencia A, Paramio JM, Real FX, Serrano M.
    J Clin Invest; 2015 Feb 15; 125(2):824-30. PubMed ID: 25574842
    [Abstract] [Full Text] [Related]

  • 4. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
    Wang K, Zhang Q, Li D, Ching K, Zhang C, Zheng X, Ozeck M, Shi S, Li X, Wang H, Rejto P, Christensen J, Olson P.
    Clin Cancer Res; 2015 Mar 15; 21(6):1487-96. PubMed ID: 25564152
    [Abstract] [Full Text] [Related]

  • 5. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
    Chen J, Zhang H, Chen Y, Qiao G, Jiang W, Ni P, Liu X, Ma L.
    Exp Cell Res; 2017 Mar 01; 352(1):104-112. PubMed ID: 28161537
    [Abstract] [Full Text] [Related]

  • 6. NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.
    Zou Y, Yang R, Huang ML, Kong YG, Sheng JF, Tao ZZ, Gao L, Chen SM.
    J Exp Clin Cancer Res; 2019 Nov 07; 38(1):456. PubMed ID: 31699119
    [Abstract] [Full Text] [Related]

  • 7. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
    Zhou Z, Cui D, Sun MH, Huang JL, Deng Z, Han BM, Sun XW, Xia SJ, Sun F, Shi F.
    FASEB J; 2020 Jun 07; 34(6):7970-7988. PubMed ID: 32293074
    [Abstract] [Full Text] [Related]

  • 8. Pathobiology of Notch2 in lung cancer.
    Motooka Y, Fujino K, Sato Y, Kudoh S, Suzuki M, Ito T.
    Pathology; 2017 Aug 07; 49(5):486-493. PubMed ID: 28666642
    [Abstract] [Full Text] [Related]

  • 9. Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.
    Gifford GB, Demitrack ES, Keeley TM, Tam A, La Cunza N, Dedhia PH, Spence JR, Simeone DM, Saotome I, Louvi A, Siebel CW, Samuelson LC.
    Gut; 2017 Jun 07; 66(6):1001-1011. PubMed ID: 26933171
    [Abstract] [Full Text] [Related]

  • 10. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
    Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel C, Duyster J, Siveke JT, Dechow T.
    Oncogene; 2015 Jan 29; 34(5):578-88. PubMed ID: 24509876
    [Abstract] [Full Text] [Related]

  • 11. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
    Yen WC, Fischer MM, Axelrod F, Bond C, Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, Tang T, Wallace B, Wang M, Zhang C, Kapoun AM, Lewicki J, Gurney A, Hoey T.
    Clin Cancer Res; 2015 May 01; 21(9):2084-95. PubMed ID: 25934888
    [Abstract] [Full Text] [Related]

  • 12. The different role of Notch1 and Notch2 in astrocytic gliomas.
    Xu P, Zhang A, Jiang R, Qiu M, Kang C, Jia Z, Wang G, Han L, Fan X, Pu P.
    PLoS One; 2013 May 01; 8(1):e53654. PubMed ID: 23349727
    [Abstract] [Full Text] [Related]

  • 13. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
    Ruan ZB, Fu XL, Li W, Ye J, Wang RZ, Zhu L.
    Biomed Pharmacother; 2016 Dec 01; 84():666-673. PubMed ID: 27697639
    [Abstract] [Full Text] [Related]

  • 14. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X.
    Mol Cancer; 2015 Feb 03; 14(1):28. PubMed ID: 25645291
    [Abstract] [Full Text] [Related]

  • 15. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug 03; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 16. LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.
    Lin H, Fu L, Zhou X, Yu A, Chen Y, Liao W, Shu G, Zhang L, Tan L, Liang H, Wang Z, Deng Q, Wang J, Jin M, Chen Z, Wei J, Cao J, Chen W, Li X, Li P, Lu J, Luo J.
    Cancer Lett; 2024 Jul 01; 593():216807. PubMed ID: 38462037
    [Abstract] [Full Text] [Related]

  • 17. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
    Okuhashi Y, Itoh M, Nara N, Tohda S.
    Anticancer Res; 2013 Oct 01; 33(10):4293-8. PubMed ID: 24122995
    [Abstract] [Full Text] [Related]

  • 18. Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines.
    Hassan WA, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T.
    Lung Cancer; 2014 Dec 01; 86(3):304-10. PubMed ID: 25456735
    [Abstract] [Full Text] [Related]

  • 19. Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.
    Qu J, Song M, Xie J, Huang XY, Hu XM, Gan RH, Zhao Y, Lin LS, Chen J, Lin X, Zheng DL, Lu YG.
    Mol Cell Biochem; 2016 Jan 01; 411(1-2):135-41. PubMed ID: 26427670
    [Abstract] [Full Text] [Related]

  • 20. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D, Liou Y, Shu J, Li D, Zhang L, Chen J.
    Exp Mol Pathol; 2014 Jun 01; 96(3):411-21. PubMed ID: 24768914
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.